Home > Industries > Health Care > Leading company profile
Plunkett Research Online: Pfizer Inc

PFIZER INC (PFE:NYS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers includ.....
Pfizer Inc
Ticker: PFE
Exchange: NYS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 212 733-2323
Fax: 212 573-7851
Address: 66 Hudson Boulevard East
New York, NY 10001-2192 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
Biopharmaceutical
Therapeutics
Drug Development
Contacts
Description
Albert BourlaCEO/Chairman of the Board/Director
David DentonCFO/Executive VP
 See More
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers includ.....See More See More

Auditor: KPMG LLP
Legal Advisor:
Financial Details Compare to Industry Averages Build Custom Table Compare Companies
$USD, In whole numbers,
except marked * or %		202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Seagen Inc
NameTitleSalary (US$)Bonus (US$)
William PaoExecutive VP/Other Executive Officer
David DentonCFO/Executive VP
Albert BourlaCEO/Chairman of the Board
Mikael DolstenChief Scientific Officer/President, Divisional
Frank D'AmelioFormer CFO/Former Executive VP, Divisional
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: